multiple sclerosis Archives

Tackling the remaining challenges of multiple sclerosis

https://pharmaphorum.com/r-d/views-analysis-r-d/tackling-the-remaining-challenges-of-multiple-sclerosis/

Novartis ups 2019 guidance after strong Q2

https://pharmaphorum.com/news/novartis-ups-2019-guidance-after-strong-q2/

Understanding Multiple Sclerosis

https://pharmaphorum.com/partner-content/understanding-multiple-sclerosis/

Novartis secures initial block on Gilenya generics in US

https://pharmaphorum.com/news/novartis-secures-initial-block-on-gilenya-generics-in-us/

Celgene gets MS blockbuster-in-waiting ozanimod back on track

https://pharmaphorum.com/news/celgene-gets-ms-blockbuster-in-waiting-ozanimod-back-on-track/

German Merck shows new data backing BTK drug evobrutinib in MS

https://pharmaphorum.com/news/german-merck-shows-new-data-backing-btk-drug-evobrutinib-in-ms/

Addressing MS’ two-tier healthcare system is about ‘social justice’

https://pharmaphorum.com/views-analysis-patients/ms-two-tier-healthcare-system/

Biogen’s R&D strategy fails to impress after Alzheimer’s trial flop

https://pharmaphorum.com/news/biogens-rd-strategy-fails-to-impress-after-alzheimers-trial-flop/

European regulator restricts use of Sanofi MS drug Lemtrada

https://pharmaphorum.com/news/european-regulator-restricts-use-of-sanofi-ms-drug-lemtrada/

Search